Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
暂无分享,去创建一个
G. Bepler | G. Scagliotti | Keunchil Park | J. Soria | J. von Pawel | F. Barlesi | M. Reck | N. Iscoe | A. Chiappori | A. Bearz | F. Barata | Yan D. Zhao | N. Chouaki | A. Liepa | A. Wagle